First in-human PET study and kinetic evaluation of [¹⁸F]AS2471907 for imaging 11β-hydroxysteroid dehydrogenase type 1

Abstract

11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) catalyzes enzymatic conversion of cortisone into the stress hormone cortisol. This first-in-human brain imaging study characterizes the kinetic modeling and test-retest reproducibility of [¹⁸F]AS2471907, a novel PET radiotracer for 11β-HSD1. Eight individuals underwent one 180-min (<i>n</i> = 4) or two 240-min (<i>n</i> = 4) [¹⁸F]AS2471907 PET brain scans (12 total) acquired on the high-resolution research tomograph (HRRT) scanner with arterial blood sampling. Imaging data were modeled with 1-tissue (1T) and 2-tissue (2T) compartment models and with multilinear analysis (MA1) to estimate [¹⁸F]AS2471907 availability (<i>V</i>_T). [¹⁸F]AS2471907 demonstrated high, heterogeneous uptake throughout the brain. Of the compartment models, 2T best described [¹⁸F]AS2471907 data. Estimates of <i>V</i>_T were highly correlated between 2T and MA1 (<i>t*</i> = 30 min) with MA1 yielding <i>V</i>_T values ranging from 3.2 ± 1.0 mL/cm³ in the caudate to 15.7 ± 4.2 mL/cm³ in the occipital cortex. The median absolute test-retest variability of 16 ± 5% and high intraclass correlation coefficient (ICC) values of 0.67-0.97 across regions indicate fair test-retest reliability but large intersubject variability. <i>V</i>_T estimates using 180 min were within 10% of estimates using full acquisition time. In summary, [¹⁸F]AS2471907 exhibits reasonable kinetic properties for imaging 11β-HSD1 in human brain.